1.
Froetschl R. Regulatory considerations related to mutagenic impurities in pharmaceuticals. sema [Internet]. 2023 May 12 [cited 2024 Feb. 21];27(1):188. Available from: https://ojs.diffundit.com/index.php/sema/article/view/1415